Pathologic aspects of tumors of gastrointestinal tract in the era of personalized medicine.
作者信息
Wang Jun
机构信息
Department of Pathology and Laboratory Medicine, Loma Linda University Medical Center, Loma Linda, California, USA.
出版信息
J Gastrointest Oncol. 2012 Sep;3(3):151-2. doi: 10.3978/j.issn.2078-6891.2012.039.
Abstract
摘要
相似文献
1
Pathologic aspects of tumors of gastrointestinal tract in the era of personalized medicine.个性化医疗时代胃肠道肿瘤的病理学特征
J Gastrointest Oncol. 2012 Sep;3(3):151-2. doi: 10.3978/j.issn.2078-6891.2012.039.
2
Personalized Medicine in a New Genomic Era: Ethical and Legal Aspects.新基因组时代的个性化医疗：伦理与法律问题
Sci Eng Ethics. 2017 Aug;23(4):1207-1212. doi: 10.1007/s11948-016-9828-4. Epub 2016 Nov 28.
3
Current prognostic and predictive biomarkers for gastrointestinal tumors in clinical practice.临床实践中用于胃肠道肿瘤的当前预后和预测生物标志物。
Pathologica. 2020 Sep;112(3):248-259. doi: 10.32074/1591-951X-158.
4
Gastrointestinal Mesenchymal Neoplasms other than Gastrointestinal Stromal Tumors: Focusing on Their Molecular Aspects.非胃肠道间质瘤的胃肠道间叶性肿瘤：聚焦于其分子层面
Patholog Res Int. 2011 Feb 16;2011:952569. doi: 10.4061/2011/952569.
5
Emerging aspects of food and nutrition on gut microbiota.食物和营养对肠道微生物群的新兴影响。
J Agric Food Chem. 2013 Oct 9;61(40):9559-74. doi: 10.1021/jf4029046. Epub 2013 Sep 27.
6
Primary leiomyosarcomas of the gastrointestinal tract in the post-gastrointestinal stromal tumor era.胃肠道间质瘤时代后的原发性胃肠道平滑肌肉瘤
Ann Diagn Pathol. 2012 Dec;16(6):532-40. doi: 10.1016/j.anndiagpath.2012.07.005. Epub 2012 Aug 20.
7
Nonstandard personalized medicine strategies for cancer may lead to improved patient outcomes.非标准的癌症个性化医疗策略可能会改善患者的治疗效果。
Per Med. 2014 Sep;11(7):705-719. doi: 10.2217/pme.14.57.
8
Personalized healthcare in the era of value-based healthcare.
Per Med. 2013 May;10(3):285-293. doi: 10.2217/pme.13.14.
9
Medical student preparedness for an era of personalized medicine: findings from one US medical school.医学生对个性化医疗时代的准备情况：来自美国一所医学院的研究结果。
Per Med. 2016 Mar;13(2):129-141. doi: 10.2217/pme.15.58.
10
The new era of personalized medicine: 10 years later.个性化医疗的新时代：十年之后。
Per Med. 2009 Jul;6(4):423-428. doi: 10.2217/pme.09.24.
本文引用的文献
1
Role of cytopathology in the diagnosis and management of gastrointestinal tract cancers.细胞病理学在胃肠道癌的诊断和治疗中的作用。
J Gastrointest Oncol. 2012 Sep;3(3):285-98. doi: 10.3978/j.issn.2078-6891.2012.023.
2
Immunohistochemical features of the gastrointestinal tract tumors.胃肠道肿瘤的免疫组织化学特征。
J Gastrointest Oncol. 2012 Sep;3(3):262-84. doi: 10.3978/j.issn.2078-6891.2012.019.
3
Gastric cancer: Classification, histology and application of molecular pathology.胃癌：分类、组织病理学和分子病理学的应用。
J Gastrointest Oncol. 2012 Sep;3(3):251-61. doi: 10.3978/j.issn.2078-6891.2012.021.
4
Genetics and molecular pathology of gastric malignancy: Development of targeted therapies in the era of personalized medicine.胃恶性肿瘤的遗传学和分子病理学：个体化医学时代的靶向治疗发展。
J Gastrointest Oncol. 2012 Sep;3(3):243-51. doi: 10.3978/j.issn.2078-6891.2012.017.
5
Barrett's esophagus: A review of diagnostic criteria, clinical surveillance practices and new developments.巴雷特食管：诊断标准、临床监测实践及新进展综述。
J Gastrointest Oncol. 2012 Sep;3(3):232-42. doi: 10.3978/j.issn.2078-6891.2012.028.
6
The association between obesity factor and esophageal caner.肥胖因素与食管癌的关系。
J Gastrointest Oncol. 2012 Sep;3(3):226-31. doi: 10.3978/j.issn.2078-6891.2012.026.
7
Gastrointestinal lymphomas: Morphology, immunophenotype and molecular features.胃肠道淋巴瘤：形态学、免疫表型和分子特征。
J Gastrointest Oncol. 2012 Sep;3(3):209-25. doi: 10.3978/j.issn.2078-6891.2012.024.
8
Gastrointestinal stromal tumor.胃肠道间质瘤。
J Gastrointest Oncol. 2012 Sep;3(3):189-208. doi: 10.3978/j.issn.2078-6891.2012.031.
9
Molecular pathology of pancreatic neuroendocrine tumors.胰腺神经内分泌肿瘤的分子病理学。
J Gastrointest Oncol. 2012 Sep;3(3):182-8. doi: 10.3978/j.issn.2078-6891.2012.018.
10
Alcoholic liver disease - Hepatocellular carcinoma transformation.酒精性肝病 - 肝细胞癌转化
J Gastrointest Oncol. 2012 Sep;3(3):174-81. doi: 10.3978/j.issn.2078-6891.2012.025.
Zotero 插件